Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases
Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …
are well established in the clinical application of cancer chemotherapy. However, the …
Recent advances in gold–NHC complexes with biological properties
This tutorial review covers the recent advances made in the study of gold complexes
containing N-heterocyclic carbene ligands with biological properties. The great stability …
containing N-heterocyclic carbene ligands with biological properties. The great stability …
Metal drugs and the anticancer immune response
B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …
[HTML][HTML] Advances in the design of organometallic anticancer complexes
P Zhang, PJ Sadler - Journal of Organometallic Chemistry, 2017 - Elsevier
Organometallic complexes containing ligands such as CO, carbenes, alkyls, phenyls, π-
bound alkynes, alkenes, cyclopentadienyls and arenes possess properties which have often …
bound alkynes, alkenes, cyclopentadienyls and arenes possess properties which have often …
Gold-based medicine: a paradigm shift in anti-cancer therapy?
CI Yeo, KK Ooi, ERT Tiekink - Molecules, 2018 - mdpi.com
A new era of metal-based drugs started in the 1960s, heralded by the discovery of potent
platinum-based complexes, commencing with cisplatin [(H3N) 2PtCl2], which are effective …
platinum-based complexes, commencing with cisplatin [(H3N) 2PtCl2], which are effective …
Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium
T Zou, CN Lok, PK Wan, ZF Zhang, SK Fung… - Current opinion in …, 2018 - Elsevier
Highlights•Metal-NHC complexes have their metal centers stabilized under physiological
conditions and can exhibit anticancer activity.•Metal-NHC complexes having new …
conditions and can exhibit anticancer activity.•Metal-NHC complexes having new …
New insights in Au-NHCs complexes as anticancer agents
Within the research field of antitumor metal-based agents alternative to platinum drugs, gold
(I/III) coordination complexes have always been in the forefront due mainly to the familiarity …
(I/III) coordination complexes have always been in the forefront due mainly to the familiarity …
Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
J Zhang, B Zhang, X Li, X Han, R Liu… - Medicinal research …, 2019 - Wiley Online Library
Mammalian thioredoxin reductase (TrxR) enzymes are homodimeric flavin proteins sharing
a unique yet essential selenocysteine residue at their C‐terminus. TrxRs, together with their …
a unique yet essential selenocysteine residue at their C‐terminus. TrxRs, together with their …
The thioredoxin system: a promising target for cancer drug development
The thioredoxin system is highly conserved system found in all living cells and comprises
NADPH, thioredoxin, and thioredoxin reductase. This system plays a critical role in …
NADPH, thioredoxin, and thioredoxin reductase. This system plays a critical role in …
Scope of organometallic compounds based on transition metal-arene systems as anticancer agents: starting from the classical paradigm to targeting multiple …
The advent of the clinically approved drug cisplatin started a new era in the design of
metallodrugs for cancer chemotherapy. However, to date, there has not been much success …
metallodrugs for cancer chemotherapy. However, to date, there has not been much success …